[HSF] More Bad News About Trasylol

[Tdmartin2000 at aol.com]

Don't believe everything you read in the New York times. The FDA panel as I 
understand it was very critical of the Mangano paper in the NEJM and the 
initial committee review was in favor of Aprotinin, The problem with the study that 
was not reviewed was that the  Bayer folks didn't even let the panel know that 
the study was being done or was near completion. 

My prediction is that aprotinin will be vindicated on most accounts.
Bleeding and transfusions are bad and should be avoided if at all possible. I 
can only relate that in the JHW group we use aprotinin in every case (along 
with a lot of other measures) and anecdotally we have fewer complications in 
this group. 
I too have nothing to do with the Bayer corp.

Tom Martin
U of Florida
Gainesville